A phase 1 study of MM-121 (a fully human monoclonal antibody targeting
- This topic has 0 replies, 1 voice, and was last updated 10 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A phase 1 study of MM-121 (a fully human monoclonal antibody targeting the epidermal growth factor receptor family member ErbB3) in combination with cetuximab and irinotecan in patients with advanced cancers.
http://abstracts.asco.org/144/AbstView_144_133896.html
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.